ArticleHemaSphere2025

Towards personalized medicine for refractory/relapsed follicular lymphoma patients: The Lupiae-Cantera study.

Irene Dogliotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.